Navigation Links
Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
Date:4/4/2013

CAMBRIDGE, Mass., April 4, 2013 /PRNewswire-USNewswire/ -- Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) today announced that one cohort of a Phase 2 non-small cell lung cancer (NSCLC) study did not meet its primary endpoint. The cohort evaluated MM-121 in combination with erlotinib to treat patients with NSCLC whose disease progressed on an anti-EGFR tyrosine kinase inhibitor (EGFR-TKI). MM-121 is being evaluated in two additional NSCLC cohorts as well as Phase 2 studies for the treatment of advanced ovarian cancer, hormone-receptor positive breast cancer and HER2 negative breast cancer.

The primary objective of this 50 patient, single arm study was to determine the potential of MM-121, a novel signaling inhibitor targeting ErbB3, to modulate or reverse resistance to erlotinib, an EGFR targeted therapy, commonly used in the treatment of NSCLC, in patients who have acquired resistance to EGFR-TKI therapy.  The primary endpoint of this cohort was to obtain a 40 percent progression free survival rate at four months of treatment. Secondary endpoints included biomarker assessment of patients enrolled in the study.

A secondary objective of the study was to evaluate tissue samples from patient biopsies to assess whether the biomarker hypothesis behind MM-121 could be translated into a clinical setting. In order to conduct this analysis, pre-dose biopsies were required from each patient upon entering the study.

"These are data on the first of three NSCLC patient populations where we are studying the potential benefit of MM-121 in combination with erlotinib. A strong component of these studies is a focused translational program directed toward the identification of a biomarker profile for the combination in this difficult to treat cancer," said Akos Czibere , MD, PhD, S
'/>"/>

SOURCE Merrimack Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
2. Valeant Pharmaceuticals Provides Update to Recent Event
3. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
4. Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash
5. European Nuclear Medicine / Radiopharmaceuticals Market Worth by Reach $1.6 Billion by 2017
6. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
7. Valeant Pharmaceuticals Announces Private Exchange Offer
8. Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs
9. Inovio Pharmaceuticals to Present at BioCenturys "Future Leaders in the Biotech Industry" Conference
10. Convergence Pharmaceuticals Announces Successful Interim Data from Ground-Breaking Phase II Trigeminal Neuralgia Study
11. Pharmaceuticals - Scandinavia Industry Guide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015  Research and ... its sixth Medical Affairs Roundtable on ... via a virtual roundtable to discuss "Medical Affairs, ... Best Practices, Medical Affairs Consortium provides Medical ... about the key challenges they face. The consortium ...
(Date:5/22/2015)... TORONTO , May 22 2015 /CNW/ - The Taskforce ... are very appreciative of all the hard work that the ... the past six months. This program recognizes the needs of ... receive at least $75,000 a year, tax free, with annual ... will be eligible for annual payments of $100,000 based on ...
(Date:5/22/2015)... OAKS, Calif. , May 22, 2015 ... announced the Company has commenced termination of ... of brodalumab with AstraZeneca (LON:AZN, STO:AZN and ... IL-17 inhibitor, is in development for patients ... axial spondyloarthritis.  The decision was based on ...
Breaking Medicine Technology:Best Practices Sixth Medical Affairs Consortium Roundtable to Focus on Health Economics & Outcomes Research 2Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5
(Date:5/24/2015)... Scientists with Cardno ChemRisk, a scientific consulting firm, ... that may have raised the risk of mesothelioma for ... an article on the research. Click here to ... asbestos levels well above OSHA safety guidelines when they ... “Asbestos compliance sampling data associated with the construction, automotive ...
(Date:5/24/2015)... York (PRWEB) May 24, 2015 ... lawsuits ( http://www.testosteronelawsuithub.com/ ) has scheduled its next ... of the multidistrict litigation. According to court documents ... of Illinois, the Conference will be convened on ... Testosterone Replacement Therapy Product Liability Litigation - MDL ...
(Date:5/24/2015)... Indiana Fiber Network, LLC (IFN), the leading Indiana ... Inc. (MTA) has selected IFN as a fiber transport ... Sales Manager, fiber route diversity and network redundancy are ... MTA with the diverse fiber transport from their Merrillville ... voice carriers located at Henry Street in Indianapolis, IN. ...
(Date:5/24/2015)... May 24, 2015 ... CEO - The students were ... at the fourth annual A Day ... at Geneva National in Lake Geneva. ...     -Badger High School,         Jonathan Alfonso,         Bridget ...
(Date:5/23/2015)... Florida City, FL (PRWEB) May 23, 2015 ... together to build a new playground for Branches Florida City ... destroyed the former play space in 2010. , A large ... then new playground on May 23, 2010 in the middle ... families watched. The fire was later declared arson even though ...
Breaking Medicine News(10 mins):Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Five Years After Fire, Branches Rebuilds Playground 2
... to implement rigorous sunscreen standards and approve more effective ... , WASHINGTON, Nov. 20 ... experts from New York Presbyterian Hospital; the Skin Cancer ... LTD, and Ciba Corporation to call on the Food ...
... found hi-tech method improved compliance more than paper and pencil ... letting kids have their fingers do the texting will increase ... part of successful dieting. , As a first proof that ... Carolina study shows that kids aged 5 to 13 are ...
... 20 Innovation, makers of,PharmASSIST(R) pharmacy automation ... System in Dallas, Texas has implemented the ... nine pharmacy sites.,Parkland Health & Hospital System ... as their core workflow platform. For those ...
... 400 Student AIDS Activists and Partner Schools to Combat HIV/AIDS ... 20 On November 15th, Green Family Foundation (GFF) ( ... (KCA) Co-Founder and Global Ambassador Alicia Keys and KCA Co-Founder ... activists in the second annual KCA College Student AIDS Summit. ...
... Nutraceutical,International Corporation (Nasdaq: NUTR ) today reported ... 30, 2008. , Net ... compared,to $39.9 million for the same quarter of fiscal 2007. ... $1.5 million, or $0.14 diluted earnings per,share, compared to net ...
... FOR PALLIATIVE MEDICINE , , SAN DIEGO, Nov. 20 ... San Diego Hospice and The Institute for Palliative Medicine offers the following tips ... , 1. Take care of yourself , ... well rested and taking care of yourself first and foremost. , ...
Cached Medicine News:Health News:Panel Demands FDA Action to Address Dramatic Increases in Skin Cancer in U.S. 2Health News:Panel Demands FDA Action to Address Dramatic Increases in Skin Cancer in U.S. 3Health News:Texting Food Diaries Helps Kids Stick With Diets 2Health News:Texting Food Diaries Helps Kids Stick With Diets 3Health News:Parkland Health & Hospital System Rolls Out Innovation's PharmASSIST Technology Platform Across Nine Pharmacy Sites 2Health News:Green Family Foundation Sponsors Alicia Keys' Keep a Child Alive College Student AIDS Summit 2Health News:Green Family Foundation Sponsors Alicia Keys' Keep a Child Alive College Student AIDS Summit 3Health News:Nutraceutical Reports 2008 Fiscal Year End Results 2Health News:Nutraceutical Reports 2008 Fiscal Year End Results 3Health News:Nutraceutical Reports 2008 Fiscal Year End Results 4Health News:Nutraceutical Reports 2008 Fiscal Year End Results 5Health News:Nutraceutical Reports 2008 Fiscal Year End Results 6Health News:Nutraceutical Reports 2008 Fiscal Year End Results 7Health News:Ten Tips for Coping with Grief and Loss During the Holidays 2Health News:Ten Tips for Coping with Grief and Loss During the Holidays 3
The versatility of multiple imaging frequencies and a smaller transducer face make this transducer is perfect for intercostal imaging....
Compact, bench-top analyser with minimal water volume requirements and easy waste management....
... AtheNA Multi-Lyte Test System* is a ... simultaneously perform multiple assays from a ... It offers a simple and streamlined ... providing improved clinical sensitivity and comparable ...
... Hamilton is precision, ergonomics, and ... hand fatigue with soft non-slip, contoured ... with smooth, light plunger spring action ... and sterilization without the need for ...
Medicine Products: